Kelly Lawrence W & Associates’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,500
Closed -$728K 171
2022
Q3
$728K Hold
1,500
0.2% 47
2022
Q2
$702K Hold
1,500
0.19% 49
2022
Q1
$653K Sell
1,500
-13,990
-90% -$5.85M 0.14% 52
2021
Q4
$7.19M Sell
15,490
-465
-3% -$206K 1.42% 26
2021
Q3
$6.21M Sell
15,955
-40
-0.3% -$17K 1.31% 26
2021
Q2
$7.08M Buy
15,995
+105
+0.7% +$45.9K 1.52% 25
2021
Q1
$6.66M Buy
15,890
+7,030
+79% +$2.81M 1.58% 25
2020
Q4
$3.63M Buy
8,860
+8,810
+17,620% +$3.66M 1.44% 25
2020
Q3
$21K Hold
50
0.01% 109
2020
Q2
$19K Buy
+50
New +$18.7K ﹤0.01% 105

Other funds holding HUM

Kelly Lawrence W & Associates's HUM Position: Q4 2022 in Review

Kelly Lawrence W & Associates sold out of Humana (HUM) in Q4 2022, closing a stake of 1,500 shares — an estimated $728K sold.

Kelly Lawrence W & Associates first reported a position in HUM in Q2 2020 and held it in 10 quarters. The position peaked at $7.19M in Q4 2021. 1,077 funds tracked by Wall St. Rank hold HUM as of Q4 2022.

  • Kelly Lawrence W & Associates reported no remaining Humana position as of Q4 2022 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 1,500 Humana shares in Q4 2022, an estimated $728K.
  • Kelly Lawrence W & Associates first reported a position in Humana in Q2 2020 and held it in 10 quarters.
  • Kelly Lawrence W & Associates's Humana position peaked at $7.19M in Q4 2021.
  • 1,077 funds tracked by Wall St. Rank held Humana as of Q4 2022.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2022, filed 14 Feb 2023.